{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih4tjwii3priqtnsit332keh4xw37kwwlgwt66laixwpkqjgakebu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mmrskktsle32"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifc2fx5hnf6ghsp73mohu7idqnnolk4ucwrfoqfxrjcwzei6l3u5q"
    },
    "mimeType": "image/jpeg",
    "size": 336956
  },
  "path": "/news/2026-05-blocking-cancer-pathways-curb-medulloblastoma.html",
  "publishedAt": "2026-05-26T16:00:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are encouraging. But for a subset, remission is not the end of the story. Roughly 30% of patients will see their cancer return, and once it does, outcomes are often devastating.",
  "title": "Blocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests"
}